Ackerman Richard (CIK 0001724016)

Latest company ownership

Shares held
160,000
Last filed at
May 25, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 29, 2017 Dec 4, 2017 NRX Pharmaceuticals, Inc. CEO Buy 90.0 +22,500 9.00% ✗ $225K